|Bid||1.1300 x N/A|
|Ask||1.1500 x N/A|
|Day's Range||1.1300 - 1.1800|
|52 Week Range||1.0200 - 5.0500|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.78|
TORONTO — Canopy Rivers Inc. says it swung to a loss in its third quarter of 2020 and has withdrawn its full-year guidance over multiple headwinds in the cannabis industry.The venture capital arm of Canopy Growth says it had a net loss of $2.7 million, or one cent per share, for the three months ending Dec. 31, compared with a net income of $1.4 million, or one cent per share, a year earlier.Analysts had expected a net loss of two cents per share, according to financial markets data firm Refinitiv.Canopy Rivers says it has withdrawn its full year guidance because uncertainty created in the industry from unanticipated licensing delays, "reformed views" on the ramp-up time for large-scale cannabis greenhouses, and a general decline in wholesale cannabis prices.The firm, which holds investments in numerous cannabis firms, had previously expected earnings before deductions of between $85 million and $100 million from its PharmaHouse and Vert Mirabel holdings.Canada's cannabis industry has struggled to reach profitability since legalization of marijuana products and companies have turned to cost cutting measures.This report by The Canadian Press was first published Feb. 14, 2020.Companies in this story: (TSX:RIV) The Canadian PressNote to readers: This is a corrected story. A previous version contained incorrect income and earnings per share figures.
Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
TORONTO, Feb. 7, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that Canopy Rivers Corporation ("Canopy Rivers") subscribed for 2,380,952 units (each a "Unit") of James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) at a price of $0.21 per Unit for total consideration of approximately $500,000 in connection with JWC's non-brokered private placement financing (the "Offering"). Each Unit is comprised of one common share in the capital of JWC (each a "Common Share") and one-half of one Common Share purchase warrant (each full warrant, a "Warrant").
TORONTO, Feb. 6, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and its portfolio companies have made a series of recent announcements that include a board appointment for Canopy Rivers' President & CEO, one brand's retail launch in Canada, and a founder and portfolio company receiving awards for their accomplishments. Other Canopy Rivers portfolio companies hit the milestones required to help further expand and build out their facilities.
TORONTO, Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada, and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.
TORONTO, Feb. 5, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that as of February 4, 2020 Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of CRI, has amended the terms of its recent US$10 million loan (the "Loan") to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly‑owned subsidiary of TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The Loan, announced October 2, 2019, included the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of C$1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of TerrAscend allowing for the purchase of common shares of TerrAscend (the "Common Shares") (the "Original Warrants") with an exercise price of C$6.49.
TORONTO , Jan. 24, 2020 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its third ...
TORONTO , Jan. 17, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies have made a series of recent announcements relating to their plans for the cannabis retail market or U.S. cannabis operations. Two portfolio companies are evaluating opportunities to expand their retail footprint in Canada , while another will remember 2019 as the year it grew its retail presence across the U.S., Canada , and Europe . Another Canopy Rivers portfolio company is taking steps to build out its U.S. operations, as more states look to legalize medical or recreational cannabis.
Beer, wine and spirit giants and small startups alike are betting on cannabis beverages disrupting the drinks market with products that can soothe sore muscles after a workout, or deliver a hangover-free buzz.
TORONTO, Jan. 8, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply its proprietary ultraviolet ("UV") light technology to medical cannabis. While BioLumic's approach has been successful in increasing yields in certain crops, such as strawberries, by up to 60%, this approval marks the first time the company's UV light technology will be used on cannabis.
TORONTO , Dec. 12, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies made several announcements that demonstrate the portfolio's continued growth heading into 2020. Among others, this includes new features from a business intelligence and analytics software platform, a licensed producer responding to consumer demands for high-THC products with the launch of four new cannabis strains, and a portfolio company expanding its retail footprint. Headset, Inc. ("Headset") launched the Demand Planning add-on to help its customers understand the "when" of the retail cannabis industry.
James E. Wagner Cultivation (TSXV: JWCA) (OTCQX: JWCAF), a portfolio company of Canopy Rivers (TSX: RIV) (OTC: CNPOF), has been granted approval by Health Canada to increase cannabis production at its facility in Kitchener, Ontario. The approval allows the company to start the production in four new flowering rooms at its facility in Kitchener. The additional […]The post Canopy Rivers Gets Approval to Boost Cannabis Production appeared first on Market Exclusive.
Supreme Cannabis (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) has reported its financial results for the fourth quarter and fiscal year ended June 30, 2019. Revenue was C$19.01 million, up from C$3.55 million for the fourth quarter of 2018. Net loss for the quatre was C$421,000, compared to a profit of C$234,000 for the same period last […]The post Cannabis Stock News Daily Roundup September 18 appeared first on Market Exclusive.
Canopy Rivers (TSX: RIV) (OTC: CNPOF) said that its class A subordinated voting shares will begin trading on the Toronto Stock Exchange under the ticker symbol "RIV" on Sept. 9. On September 24, 2019, Canopy will participate in the TSX market open ceremony. Canopy is focused on investment opportunities in the global cannabis sector. The company identifies […]The post Cannabis Stock News Daily Roundup September 11 appeared first on Market Exclusive.